Brain stimulation reward (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Brain stimulation reward" in English language version.

refsWebsite
Global rank English rank
4th place
4th place
2nd place
2nd place
11th place
8th place
228th place
158th place

doi.org

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Wise RA (1996). "Addictive drugs and brain stimulation reward". Annual Review of Neuroscience. 19: 319–40. doi:10.1146/annurev.ne.19.030196.001535. PMID 8833446.
  • Wise RA (October 2002). "Brain reward circuitry: insights from unsensed incentives". Neuron. 36 (2): 229–40. doi:10.1016/s0896-6273(02)00965-0. PMID 12383779.
  • Wise RA, Rompre PP (1989). "Brain dopamine and reward". Annual Review of Psychology. 40: 191–225. doi:10.1146/annurev.ps.40.020189.001203. PMID 2648975.
  • Carlezon WA, Chartoff EH (2007). "Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation". Nature Protocols. 2 (11): 2987–95. doi:10.1038/nprot.2007.441. PMID 18007634. S2CID 13085385.
  • Negus SS, Miller LL (July 2014). "Intracranial self-stimulation to evaluate abuse potential of drugs". Pharmacological Reviews. 66 (3): 869–917. doi:10.1124/pr.112.007419. PMC 4081730. PMID 24973197.
  • Olds J, Milner P (1954). "Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain". Journal of Comparative and Physiological Psychology. 47 (6): 419–27. doi:10.1037/h0058775. PMID 13233369.
  • Milner PM (1991). "Brain-stimulation reward: a review". Canadian Journal of Psychology. 45 (1): 1–36. doi:10.1037/h0084275. PMID 2044020.
  • Heath RG (December 1963). "Electrical self-stimulation of the brain in man". The American Journal of Psychiatry. 120 (6): 571–7. doi:10.1176/ajp.120.6.571. PMID 14086435.
  • Berridge, K. C. (2003). "Pleasures of the brain". Brain and Cognition. 52 (1): 106–128. doi:10.1016/S0278-2626(03)00014-9. PMID 12812810. S2CID 6640313.
  • Olds J (1958). "Self-stimulation of the brain; its use to study local effects of hunger, sex, and drugs". Science. 127 (3294): 315–24. doi:10.1126/science.127.3294.315. PMID 13506579. S2CID 6411230.
  • Bozarth MA, Wise RA (1985). "Toxicity associated with long-term intravenous heroin and cocaine self-administration in the rat". JAMA. 254 (1): 81–3. doi:10.1001/jama.1985.03360010087032. PMID 4039767.
  • Kokarovtseva L, Jaciw-Zurakiwsky T, Mendizabal Arbocco R, Frantseva MV, Perez Velazquez JL (2009). "Excitability and gap junction-mediated mechanisms in nucleus accumbens regulate self-stimulation reward in rats". Neuroscience. 159 (4): 1257–63. doi:10.1016/j.neuroscience.2009.01.065. PMID 19409225. S2CID 12059974.
  • Sonnenschein B, Conover K, Shizgal P (2003). "Growth of brain stimulation reward as a function of duration and stimulation strength". Behavioral Neuroscience. 117 (5): 978–94. doi:10.1037/0735-7044.117.5.978. PMID 14570548.
  • Phillips TJ, Reed C (November 2014). "Targeting GABAB receptors for anti-abuse drug discovery". Expert Opinion on Drug Discovery. 9 (11): 1307–17. doi:10.1517/17460441.2014.956076. PMID 25195620. S2CID 2310286.
  • Liebman JM (1983). "Discriminating between reward and performance: a critical review of intracranial self-stimulation methodology". Neuroscience and Biobehavioral Reviews. 7 (1): 45–72. doi:10.1016/0149-7634(83)90007-6. PMID 6132357. S2CID 26513856.
  • Phillips AG, Blaha CD, Fibiger HC (1989). "Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses". Neuroscience and Biobehavioral Reviews. 13 (2–3): 99–104. doi:10.1016/S0149-7634(89)80017-X. PMID 2530478. S2CID 11772466.
  • Barr AM, Markou A, Phillips AG (2002). "A 'crash' course on psychostimulant withdrawal as a model of depression". Trends in Pharmacological Sciences. 23 (10): 475–82. doi:10.1016/S0165-6147(02)02086-2. PMID 12368072.
  • Olds J, Travis RP (April 1960). "Effects of chlorpromazine, meprobamate, pentobarbital and morphine on self-stimulation". The Journal of Pharmacology and Experimental Therapeutics. 128: 397–404. PMID 14428622.
  • Schaefer GJ (1988). "Opiate antagonists and rewarding brain stimulation". Neuroscience and Biobehavioral Reviews. 12 (1): 1–17. doi:10.1016/s0149-7634(88)80068-x. PMID 3287237. S2CID 1075158.
  • Melroy-Greif WE, Stitzel JA, Ehringer MA (January 2016). "Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use". Genes, Brain and Behavior. 15 (1): 89–107. doi:10.1111/gbb.12251. PMC 4780670. PMID 26351737.
  • Itasaka M, Hironaka N, Miyata H (June 2015). "[Behavioral characteristics of nicotine seeking: a role of the nicotine-conditioned effects and other mechanisms]". Nihon Arukoru Yakubutsu Igakkai Zasshi = Japanese Journal of Alcohol Studies & Drug Dependence. 50 (3): 135–43. PMID 26502572.
  • Bauzo RM, Bruijnzeel AW (2012). "Animal models of nicotine withdrawal: intracranial self-stimulation and somatic signs of withdrawal". Psychiatric Disorders. Methods in Molecular Biology. Vol. 829. pp. 257–68. doi:10.1007/978-1-61779-458-2_16. ISBN 978-1-61779-457-5. PMID 22231819.
  • Kornetsky C, Bain GT, Unterwald EM, Lewis MJ (October 1988). "Brain stimulation reward: effects of ethanol". Alcoholism: Clinical and Experimental Research. 12 (5): 609–16. doi:10.1111/j.1530-0277.1988.tb00250.x. PMID 2852475.
  • Vlachou S, Markou A (2010). "GABAB receptors in reward processes". GABABReceptor Pharmacology - A Tribute to Norman Bowery. Advances in Pharmacology. Vol. 58. pp. 315–71. doi:10.1016/S1054-3589(10)58013-X. ISBN 9780123786470. PMID 20655488.
  • Yu C, McClellan J (July 2016). "Genetics of Substance Use Disorders". Child and Adolescent Psychiatric Clinics of North America. 25 (3): 377–85. doi:10.1016/j.chc.2016.02.002. PMID 27338962.
  • Yang J, Li MD (August 2016). "Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions". Molecular Psychiatry. 21 (8): 992–1008. doi:10.1038/mp.2016.67. PMC 4956568. PMID 27166759.
  • Choi HD, Shin WG (April 2016). "Meta-analysis of the association between a serotonin transporter 5-HTTLPR polymorphism and smoking cessation". Psychiatric Genetics. 26 (2): 87–91. doi:10.1097/YPG.0000000000000116. PMID 26886943. S2CID 23494040.
  • Chiamulera C, Padovani L, Corsi M (August 2017). "Drug discovery for the treatment of substance use disorders: novel targets, repurposing, and the need for new paradigms". Current Opinion in Pharmacology. 35: 120–124. doi:10.1016/j.coph.2017.08.009. PMID 28874314. S2CID 3413116.

ncbi.nlm.nih.gov

semanticscholar.org

api.semanticscholar.org

theatlantic.com